GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » EV-to-FCF

Merus Labs International (Merus Labs International) EV-to-FCF : 12.64 (As of May. 05, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Merus Labs International's Enterprise Value is $152.23 Mil. Merus Labs International's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2017 was $12.04 Mil. Therefore, Merus Labs International's EV-to-FCF for today is 12.64.

The historical rank and industry rank for Merus Labs International's EV-to-FCF or its related term are showing as below:

MSLI's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.78
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Merus Labs International's stock price is $1.30. Merus Labs International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.075. Therefore, Merus Labs International's PE Ratio for today is At Loss.


Merus Labs International EV-to-FCF Historical Data

The historical data trend for Merus Labs International's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International EV-to-FCF Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 10.48 14.56

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Merus Labs International's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus Labs International's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Merus Labs International's EV-to-FCF falls into.



Merus Labs International EV-to-FCF Calculation

Merus Labs International's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=152.230/12.04
=12.64

Merus Labs International's current Enterprise Value is $152.23 Mil.
Merus Labs International's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merus Labs International  (NAS:MSLI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Merus Labs International's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.30/-0.075
=At Loss

Merus Labs International's share price for today is $1.30.
Merus Labs International's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.075.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Merus Labs International EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Merus Labs International's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus Labs International (Merus Labs International) Business Description

Traded in Other Exchanges
N/A
Address
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines